Track the KESTRA MEDICAL TECHNOLOGIES, LTD. share price and the full management transaction log of the company, a publicly traded company based in United States. Shares trade on US US, under the oversight of SEC (Form 4). Market capitalisation: €1.6bn. The latest transaction was disclosed on 4 June 2026 (Attribution). Among the most active insiders: Ford Alfred J Jr. The full history is openly available.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
1 of 1 declaration
KESTRA MEDICAL TECHNOLOGIES, LTD. is a company focused on developing innovative medical technologies. It is listed on the XNAS market.